Vimarsana
Biggest News Aggregation in the World

Page 2 - Clinformatics Data Mart Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinformatics Data Mart Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinformatics Data Mart Database Today - Breaking & Trending Today

Translating DMD Clinical Trial Findings to Real-World Application Discouraging - Vimarsana News

Translating DMD Clinical Trial Findings to Real-World Application Discouraging

This analysis compared outcomes among patients who have Duchenne muscular dystrophy (DMD) and commercial insurance or Medicaid, focusing on how these differ between patients in clinical trials and those who receive treatment post approval.

Source: ajmc.com
One Class of Antidiabetic Linked With Lower Kidney Stone Risk - Vimarsana News

One Class of Antidiabetic Linked With Lower Kidney Stone Risk

Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes - Vimarsana News

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes

Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.

Female Patients Less Likely to Receive Guideline-Directed HFrEF Therapies vs Males - Vimarsana News

Female Patients Less Likely to Receive Guideline-Directed HFrEF Therapies vs Males

A recent study found that use of optimal guideline-directed medical therapies after heart failure with reduced ejection fraction (HFrEF) diagnosis is low overall, but especially among female patients compared with male patients.

Source: ajmc.com
Interventions Needed to Increase DMT Uptake in Sickle Cell Disease - Vimarsana News

Interventions Needed to Increase DMT Uptake in Sickle Cell Disease

A recent study found that uptake of disease-modifying therapies (DMTs) has been low among patients with sickle cell disease, suggesting that more interventions that consider individual patient characteristics are needed to improve adoption.

Source: ajmc.com